SlideShare une entreprise Scribd logo
1  sur  50
 Establish the importance of the experiment
◦ Handouts
◦ Surveymonkey.com
 62 participants
63%
37%
Question 1: Do you purchases
pharmaceuticals in Mexico?
Yes No
14%
39%
18%
29%
Question 2: Why do you not purchase the
products in Mexico?
Do Not Trust Them
Unsafe to Travel There
Too Far Away
Other
Penacillin
31%
Amoxicillin
31%
Erythromycin
1%
Lisinopril
1%
Valium
3%
Vicodin
3%
Ambien
3%
Codeine
4%
Demerol
1%
Metformin
4%
Steriod
5%
Others
13%
Question 5: What product(s) do you purchase in Mexico?
*selected all that applied
Yes
62%
No
30%
They Are Better
8%
Question 11: Do you believe that they are
of the same quality?
Cheaper
69%
No Prescription
Is Needed
10%
I Live There
5% Other
16%
Question 9: What is the primary reason you
purchase Pharmaceuticals in Mexico?
C21H30O2
314.47 g/mol
 A method to chemically modify a compound
◦ Increase volatility
◦ Decrease volatility
 Focuses on O, S, N, and P functional groups
with an active Hydrogen available
 Silylation produces silyl derivatives to
increase volatility.
◦ Replaces active H with TMS.
◦ Solvent = Pyridine
 Acylation target carbohydrates and amino
acids
 Alkylation converts organic acids into esters
by transferring an alkyl group
C16H19N3O5S = 365.4 grams/mol
 MTBSTFA = C9H18F3NOSi
 (n-methyl-n-t-butyldimethylsilytrifluoroacetamide)
◦ 10,000 times more stable
◦ Suitable for GC/MS analysis
C6H15Si
115.27 g/mol
C9H18F3NOSi
241.33 g/mol
+
 0.0154 grams Amoxicillin
 100 µL 0.85 M Acetonitrile
 20 µL MTBSTFA
 Sat Overnight
 150 µL Hexane
 *Centrifuged 15 Minutes
 1 mL of Hexane (solvent)
GC Parameters:
 Inlet – 240 ºC
 Oven temp. start at 60 ºC,
 Ramp up to 300 ºC at 40 ºC/min
 Flow rate of He = 1mL/min.
 Splitless
MS Parameters:
 Ion mode - 70 ev
 Solvent Delay 3 min.
 Scan – 50-500 amu
S1
 0.1002 g of Amoxicillin
 100 µL of Acetonitrile
 1 mL of Pyridine (Solvent)
 20 µL of MTBSTFA
S2
 0.1012 g of Amoxicillin
 100 µL of Acetonitrile
 1 mL of Methanol (Solvent)
 20 µL of MTBSTFA
S1 & S2
 *Centrifuged 20 min.
 Water bath 100 ºC 20 min.
GC Parameters:
 Inlet – 250 ºC
 Oven temp. start at 40 ºC,
 Ramp up to 340 ºC at 20 ºC/min
 Flow rate of He = 1mL/min.
 Splitless
MS Parameters:
 Ion mode - 70 ev
 Solvent Delay 3 min.
 Scan – 50-500 amu
60 ºC
 0.0983 g of Amoxicillin
 100 µL of Acetonitrile
 1 mL of Pyridine (Solvent)
 20 µL of MTBSTFA
 *Centrifuged 20 minutes
 Water Bath 60 ºC 1 hour
40 ºC
 0.1012 g of Amoxicillin
 100 µL of Acetonitrile
 1 mL of Methanol (Solvent)
 20 µL of MTBSTFA
 *Centrifuged 20 minutes
 Water Bath 40 ºC 1 hour
GC Parameters:
 Inlet – 250 ºC
 Oven temp. start at 40 ºC,
 Ramp up to 340 ºC at 20 ºC/min
 Flow rate of He = 1mL/min.
 Splitless
MS Parameters:
 Ion mode - 70 ev
 Solvent Delay 3 min.
 Scan – 50-600 amu
Handedness
 Chiral Molecule is a
molecule that is the same
but arranged in a non-
superimposable way,
typically due to Carbon
 C8H12N2O3S
 MW = 216.0568
H
GC Parameters:
 Inlet – 250 ºC
 Oven temp. start at 40 ºC,
 Ramp up to 340 ºC at 20 ºC/min
 Flow rate of He = 1mL/min.
 Splitless
MS Parameters:
 Ion mode - 70 ev
 Solvent Delay 3 min.
 Scan – 50-600 amu
GC Parameters:
 Inlet – 250 ºC
 Oven temp. start at 40 ºC,
 Ramp up to 340 ºC at 20 ºC/min
 Flow rate of He = 1mL/min.
 Splitless
MS Parameters:
 Ion mode - 70 ev
 Solvent Delay 3 min.
 Scan – 50-600 amu
Standard 1
 0.1016 g of Amoxicillin
 100 µL of Acetonitrile
 1 mL of Pyridine (Solvent)
 20 µL of MTBSTFA
Standard 2
 0.0751 g of Amoxicillin
 100 µL of Acetonitrile
 1 mL of Pyridine (Solvent)
 20 µL of MTBSTFA
Standard 3
 0.0492 g of Amoxicillin
 100 µL of Acetonitrile
 1 mL of Pyridine (Solvent)
 20 µL of MTBSTFA
Standard 4
 0.0246 g of Amoxicillin
 100 µL of Acetonitrile
 1 mL of Pyridine (Solvent)
 20 µL of MTBSTFA
Standards 1-4
 *Centrifuged 20 min.
 Water bath 100 ºC 20 min.
GC Parameters:
 Inlet – 300 ºC
 Oven temp. start at 40 ºC,
 Ramp up to 340 ºC at 20 ºC/min
 Flow rate of He = 1mL/min.
 Splitless
MS Parameters:
 Ion mode - 70 ev
 Solvent Delay 3 min.
 SCAN - 50-600 amu
GC Parameters:
 Inlet – 300 ºC
 Oven temp. start at 40 ºC,
 Ramp up to 340 ºC at 20 ºC/min
 Flow rate of He = 1mL/min.
 Splitless
MS Parameters:
 Ion mode - 70 ev
 Solvent Delay 3 min.
 SCAN – 50-600 amu
y = 48.303x + 3E+06
R² = 0.468
0
2000000
4000000
6000000
8000000
10000000
0 20000 40000 60000 80000 100000
Area
Concentration (PPM)
Graph 1: Concentration (PPM) Versus Area
y = 48.303x + 3E+06
R² = 0.5253
0
2000000
4000000
6000000
8000000
10000000
0 20000 40000 60000 80000 100000
Area
Concentration (PPM)
Graph 2: Concentration Averages (PPM) Versus
Area Averages
Name Concentration (PPM) Area Average Areas
Standard 4 21964 3124602
Standard 4 21964 3059293
Standard 4 21964 3087453
Standard 3 43929 7201948
Standard 3 43929 6591084
Standard 3 43929 6425105
Standard 2 67054 8825625
Standard 2 67054 7083085
Standard 2 67054 6681811
Standard 1 90714 6788287
Standard 1 90714 5668981
Standard 1 90714 7278867
3090449.333
6739379
7530173.667
6578711.667
Table 1: Concentration Versus Areas
GC Parameters:
 Inlet – 250 ºC
 Oven temp. start at 40 ºC,
 Ramp up to 340 ºC at 20 ºC/min
 Flow rate of He = 1mL/min.
 Splitless
MS Parameters:
 Ion mode - 70 ev
 Solvent Delay 3 min.
 SIM – 114, 142.5, 160
amu
 Syringe filtered standards into new vials
 Ran sequence in SIM Mode - 160 m/z
 Results were inconclusive
 Build up suspected
 Stock Solution 1026 PPM Amoxicillin
 Made 1000 PPB solution of Amoxicillin
Standard 1
 2 mL of 1000 PPB Solution
 0.5 mL of 5 N KOH
Standard 2
 1 mL of 1000 PPB Solution
 1 mL of DI Water
 0.5 mL of 5 N KOH
Standard 3
 0.5 mL of 1000 PPB Solution
 1.5 mL of DI Water
 0.5 mL of 5 N KOH
Standards 1-3
 Water bath 50 ºC 20 min.
 Cooled for 60 Minutes
 + 1 mL of Acetic Acid
 + 5 mL of (7:1 ratio) Hexane: Ethyl Acetate solution
 Centrifuged for 15 minutes
 Top organic layer extracted to new test tubes
 Evaporated to dryness (several days)
 + 20 μL of MTBSTFA
 + 100 μL of Acetonitrile
 Heated in heating block at 110 °C for 15 minutes
 + 0.5 methanol solvent
 Each standard tested several times
 No signs of Amoxicillin or 6-
Aminopenicillanic Acid
 Batch 4 standard dilutions
 100 μL of each respective standard into new
vial
 + 900 μL of Methanol solvent
 No signs of Amoxicillin or 6-Aminopenllinc
Acid
Test Samples 1 & 2
 Water bath 60 ºC 15 min.
 Cooled for 60 minutes
 + 1 mL of Acetic Acid
 + 5 mL of (7:1 ratio) Hexane: Ethyl Acetate solution
 Centrifuged for 15 minutes
 Top organic layer extracted to new test tubes
 Evaporated to dryness (several days)
 + 20 μL of MTBSTFA
 + 100 μL of Acetonitrile
 Heated in heating block at 110 °C for 15 minutes
 + 0.5 methanol solvent
 New Stock Solution of 10,000 PPM Amoxicillin
Test Sample 1
 2 mL of 1000 PPM Stock Solution
 0.5 mL of 5 N KOH
Test Sample 2
 2 mL of 10,000 PPM Stock Solution
 0.5 mL of 5 N KOH
 Each test sample tested several times
 No signs of Amoxicillin or 6-
Aminopenllinc Acid
 Temperature affects the 8.10 peak of 6-
Aminopenicillanic Acid
 Amoxicillin as a whole cannot be seen in
GC/MS
Standard 1
 0.9916 grams of KBR
 0.0017 grams of Amoxicillin
 0.1026 grams of Starch
Standard 2
 0.9970 grams of KBR
 0.0034 grams of Amoxicillin
 0.1003 grams of Starch
Standard 3
 1.006 grams of KBR
 0.0073 grams of Amoxicillin
 0.1000 grams of Starch
Standard 1-3
 Each standard tested 3 times
 Starch Wavelength Height Ratios = 2150
 Amoxicillin's Wavelength Height Ratios = 1775,
1687, 1686, 1685.5, 1519
2150
1775
1687
1686
1685.5
1519
Starch Abs. Ratio 1 Ratio 2 Ratio 3 Ratio 4 Ratio 5 Amox
1775 1687 1686 1685.5 1519 Height 2150 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150 Percentage
1 1.0940 1.5688 1.5560 1.5855 1.4680 0.8225 1.3301 1.9074 1.8918 1.9277 1.7848 1.630%
2 1.1990 1.5670 1.5550 1.5827 1.4540 0.8651 1.3860 1.8114 1.7975 1.8295 1.6807 1.630%
3 1.1150 1.5706 1.5570 1.5881 1.4740 0.8749 1.2744 1.7952 1.7796 1.8152 1.6848 1.630%
Averages 1.1360 1.5688 1.5560 1.5854 1.4653 0.8542 1.3302 1.8380 1.8230 1.8574 1.7168 1.630%
Starch Abs. Ratio 1 Ratio 2 Ratio 3 Ratio 4 Ratio 5 Amox
1775 1687 1686 1685.5 1519 Height 2150 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150 Percentage
1 1.2554 1.5946 1.6020 1.6060 1.4403 0.7923 1.5845 2.0126 2.0220 2.0270 1.8179 3.2787%
2 1.2709 1.5905 1.5599 1.6060 1.4439 0.8025 1.5837 1.9819 1.9438 2.0012 1.7993 3.2787%
3 1.2735 1.5934 1.6031 1.6084 1.4416 0.8105 1.5713 1.9659 1.9779 1.9845 1.7787 3.2787%
Averages 1.2666 1.5928 1.5883 1.6068 1.4419 0.8018 1.5798 1.9868 1.9812 2.0042 1.7986 3.2787%
Starch Abs. Ratio 1 Ratio 2 Ratio 3 Ratio 4 Ratio 5 Amox
1775 1687 1686 1685.5 1519 Height 2150 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150 Percentage
1 1.7942 2.2060 2.2900 2.2400 1.8740 1.0290 1.7436 2.1438 2.2255 2.1769 1.8212 6.8034%
2 1.7975 2.2030 2.2180 2.2260 1.8710 1.0395 1.7292 2.1193 2.1337 2.1414 1.7999 6.8034%
3 1.7856 2.2005 2.2165 2.0140 1.8935 0.9207 1.9394 2.3900 2.4074 2.1875 2.0566 6.8034%
Averages 1.7924 2.2032 2.2415 2.1600 1.8795 0.9964 1.8041 2.2177 2.2555 2.1678 1.8926 6.8034%
Table 1: Standard 1 Data
Table 2: Standard 2 Data
Table 3: Standard 3 Data
Run
Amoxicillin At Absorbance Height
Run
Amoxicillin At Absorbance Height
Run
Amoxicillin At Absorbance Height
1.0940/0.8225 = 1.3301
(0.0017g Amox/ (0.0017g Amox + 0.1026 g Starch)) = 1.630%
Y Axis X Axis
Starch Abs. Ratio 1 Ratio 2 Ratio 3 Ratio 4 Ratio 5
1775 1687 1686 1685.5 1519 Height 2150 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150
1 - - - - - 0.5355 - - - - -
2 - 3.9652 3.8270 3.7990 2.6780 0.5347 - 7.4157 7.1573 7.1049 5.0084
3 - 3.5608 3.5601 3.5599 2.6500 0.5342 - 6.6657 6.6644 6.6640 4.9607
Averages - 3.7630 3.6936 3.6795 2.6640 0.5348 - 7.0407 6.9108 6.8845 4.9846
Table 4: Average Ratios for Sample 1
Amoxicillin At Absorbance Height
Run
Ratio 1 Ratio 2 Ratio 3 Ratio 4 Ratio 5
1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150
1 - - - - - - - - - -
2 - 7.4157 7.1573 7.1049 5.0084 - 78.7612% 66.0248% 91.9826% 101.5664%
3 - 6.6657 6.6644 6.6640 4.9607 - 68.3662% 60.0643% 84.3602% 100.1124%
Averages - 7.0407 6.9108 6.8845 4.9846 - 73.5637% 63.0445% 88.1714% 100.8394%
Run
Percentage Based Off of Calibration Curve With Respective Ratio
Table 5: Sample 1 Determined Average Percentage Based of Multiple Calibration Curves With Respective Height Ratios
Weight
of Pill (g) 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150
1 - - - - - - - - - -
2 - 78.7612% 66.0248% 91.9826% 101.5664% - 498.0068 417.4748 581.6061 642.2041
3 - 68.3662% 60.0643% 84.3602% 100.1124% - 432.2795 379.7866 533.4094 633.0106
Averages - 73.5637% 63.0445% 88.1714% 100.8394% - 465.1431 398.6307 557.5078 637.6074
- 46.4762 26.6496 34.0802 6.5008
- 465.14 ± 46.48 398.63 ± 26.65 557.51 ± 34.08 637.61 ± 6.50
(+) - 672.6441 517.6123 709.6647 666.6314
(-) - 257.6421 279.6491 405.3509 608.5833
Standard Deviation of Average Content of Amoxicillin (mg)
Concentration of Amoxicillin (mg) and Standard Deviation
95% Confidence Interval of Amoxicillin (mg) ±Range
Run
Percent Based Off of Calibration Curve With Respective Ratio
0.6323
Concentration (mg) Based Off of Wegiht of Pill and %
Table 6: Sample 1 Determined Concentration (mg) of Amoxicillin Determined from the Weight Pill (g) & Percentage
((7.4157 – 1.7325)/7.2158)) = 78.7612%0.6323 g X 78.7612% = 498.0068
3.9650/0.5347 = 7.4157
Starch Abs. Ratio 1 Ratio 2 Ratio 3 Ratio 4 Ratio 5
1775 1687 1686 1685.5 1519 Height 2150 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150
1 2.5618 2.4935 2.5085 2.5160 1.9151 0.4569 5.6069 5.4574 5.4903 5.5067 4.1915
2 2.6050 2.4635 2.4862 2.4975 1.9185 0.4585 5.6816 5.3730 5.4225 5.4471 4.1843
3 2.5980 2.4507 2.4546 2.4560 1.9208 0.4579 5.6737 5.3520 5.3606 5.3636 4.1948
Averages 2.5883 2.4692 2.4831 2.4898 1.9181 0.4578 5.6541 5.3941 5.4244 5.4391 4.1902
Table 7: Average Ratios for Sample 2
Run
Amoxicillin At Absorbance Height
Ratio 1 Ratio 2 Ratio 3 Ratio 4 Ratio 5
1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150
1 5.6069 5.4574 5.4903 5.5067 4.1915 50.1877% 51.6219% 45.8671% 64.3538% 76.6796%
2 5.6816 5.3730 5.4225 5.4471 4.1843 51.0439% 50.4512% 45.0473% 63.3241% 76.4599%
3 5.6737 5.3520 5.3606 5.3636 4.1948 50.9540% 50.1613% 44.2987% 61.8808% 76.7800%
Averages 5.6541 5.3941 5.4244 5.4391 4.1902 50.7285% 50.7448% 45.0710% 63.1862% 76.6398%
Table 8: Sample 2 Determined Average Percentage Based of Multiple Calibration Curves With Respective Height Ratios
Run
Percentage Based Off of Calibration Curve With Respective Ratio
Weight
of Pill (g) 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150
1 50.1877% 51.6219% 45.8671% 64.3538% 76.6796% 289.6834 297.9614 264.7447 371.4502 442.5947
2 51.0439% 50.4512% 45.0473% 63.3241% 76.4599% 294.6255 291.2041 260.0129 365.5068 441.3266
3 50.9540% 50.1613% 44.2987% 61.8808% 76.7800% 294.1063 289.5313 255.6922 357.1758 443.1740
Averages 50.7285% 50.7448% 45.0710% 63.1862% 76.6398% 292.8051 292.8989 260.1499 364.7109 442.3651
2.7159 4.4633 4.5278 7.1704 0.9448
292.81 ± 2.72 292.90 ± 4.46 260.15 ± 4.53 364.71 ± 7.17 442.37 ± 0.94
(+) 297.3837 300.4235 267.7832 376.7993 443.9579
(-) 288.2265 285.3744 252.5166 352.6226 440.7722
Concentration of Amoxicillin (mg) and Standard Deviation
Concentration (mg) Based Off of Wegiht of Pill and %
Table 9: Sample 2 Determined Concentration (mg) of Amoxicillin Determined from the Weight Pill (g) & Percentage
Run
Percent Based Off of Calibration Curve With Respective Ratio
0.5772
95% Confidence Interval of Amoxicillin (mg) ± Range
Standard Deviation of Average Content of Amoxicillin (mg)
Starch Abs. Ratio 1 Ratio 2 Ratio 3 Ratio 4 Ratio 5
1775 1687 1686 1685.5 1519 Height 2150 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150
1 4.0998 - - - 3.2080 0.7082 5.7890 - - - 4.5298
2 5.6195 3.4923 3.5105 3.5195 3.2560 0.7055 7.9653 4.9501 4.9759 4.9887 4.6152
3 3.7330 5.0030 5.1712 5.9810 3.2286 0.7037 5.3048 7.1096 7.3486 8.4994 4.5880
Averages 4.4841 4.2477 4.3409 4.7503 3.2309 0.7058 6.3530 6.0298 6.1622 6.7440 4.5777
Table 10: Average Ratios for Sample 3
Run
Amoxicillin At Absorbance Height
Ratio 1 Ratio 2 Ratio 3 Ratio 4 Ratio 5
1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150
1 5.7890 - - - 4.5298 52.2765% - - - 86.9853%
2 7.9653 4.9501 4.9759 4.9887 4.6152 77.2359% 44.5911% 39.6474% 55.3989% 89.5862%
3 5.3048 7.1096 7.3486 8.4994 4.5880 46.7229% 74.5179% 68.3380% 116.0883% 88.7596%
Averages 6.3530 6.0298 6.1622 6.7440 4.5777 58.7451% 59.5545% 53.9927% 85.7436% 88.4437%
Table 11: Sample 3 Determined Average Percentage Based of Multiple Calibration Curves With Respective Height Ratios
Run
Percentage Based Off of Calibration Curve With Respective Ratio
Weight
of Pill (g) 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150
1 52.2765% - - - 86.9853% 312.7182 - - - 520.3463
2 77.2359% 44.5911% 39.6474% 55.3989% 89.5862% 462.0250 266.7441 237.1710 331.3963 535.9046
3 46.7229% 74.5179% 68.3380% 116.0883% 88.7596% 279.4965 445.7662 408.7980 694.4403 530.9601
Averages 58.7451% 59.5545% 53.9927% 85.7436% 88.4437% 351.4132 356.2551 322.9845 512.9183 529.0703
97.2221 126.5877 121.3587 256.7109 7.9494
351.41 ± 97.22 356.26 ± 126.59 322.98 ± 121.36 512.92 ± 256.71 529.07 ± 7.95
(+) 515.3164 921.4278 864.8111 1659.0482 542.4719
(-) 187.5100 -208.9175 -218.8421 80.1389 515.6687
Concentration of Amoxicillin (mg) and Standard Deviation
95% Confidence Interval of Amoxicillin (mg) ± Range
0.5982
Standard Deviation of Average Content of Amoxicillin (mg)
Percent Based Off of Calibration Curve With Respective Ratio Concentration (mg) Based Off of Wegiht of Pill and %
Table 12: Sample 3 Determined Concentration (mg) of Amoxicillin Determined from the Weight Pill (g) & Percentage
Run
465.14mg ± 46.48mg
292.81mg ± 2.72mg
Or
442.37mg ± 0.94mg
529.07mg ± 7.95mg
 Somewhat possible view Amoxicillin through
GC/MS
 Further testing of Amoxicillin Sample 2
through
An Analysis of Amoxicillin Through GC/MS and Later FTIR Presentation

Contenu connexe

Tendances

B. Pharm. (Honours) Part-III Practical, Medicinal Chemistry,Manik
B. Pharm. (Honours) Part-III Practical, Medicinal Chemistry,ManikB. Pharm. (Honours) Part-III Practical, Medicinal Chemistry,Manik
B. Pharm. (Honours) Part-III Practical, Medicinal Chemistry,ManikImran Nur Manik
 
Medicinal chemistry i practicals
Medicinal chemistry  i  practicalsMedicinal chemistry  i  practicals
Medicinal chemistry i practicalsMonika Shirke
 
IMViC Biochemical Tests Principle|Indole|Methyl Red|Voges Proskauer|Citrate Test
IMViC Biochemical Tests Principle|Indole|Methyl Red|Voges Proskauer|Citrate TestIMViC Biochemical Tests Principle|Indole|Methyl Red|Voges Proskauer|Citrate Test
IMViC Biochemical Tests Principle|Indole|Methyl Red|Voges Proskauer|Citrate TestFreya Cardozo
 
Proximat analysis laboratory + proximat analysis
Proximat analysis laboratory + proximat analysisProximat analysis laboratory + proximat analysis
Proximat analysis laboratory + proximat analysisAsif Sahir
 
Medicinal chemistry (Practical) MANIK
Medicinal chemistry (Practical) MANIKMedicinal chemistry (Practical) MANIK
Medicinal chemistry (Practical) MANIKImran Nur Manik
 
Synthesis of 7 hydroxy-4-methyl coumarin
Synthesis of 7 hydroxy-4-methyl coumarinSynthesis of 7 hydroxy-4-methyl coumarin
Synthesis of 7 hydroxy-4-methyl coumarinkiran2mane
 
Effect of the amount of worms on Organic matter degradation in cattle manure ...
Effect of the amount of worms on Organic matter degradation in cattle manure ...Effect of the amount of worms on Organic matter degradation in cattle manure ...
Effect of the amount of worms on Organic matter degradation in cattle manure ...Akib Sumon
 
Preparation of reagents for Qualitative analysis of salts MANIK
Preparation of reagents  for Qualitative analysis of salts MANIKPreparation of reagents  for Qualitative analysis of salts MANIK
Preparation of reagents for Qualitative analysis of salts MANIKImran Nur Manik
 
Oxandrolone (Anavar) powder (CAS 53-39-4 )COA- AASraw Steroid powder
Oxandrolone (Anavar) powder (CAS 53-39-4 )COA- AASraw Steroid powderOxandrolone (Anavar) powder (CAS 53-39-4 )COA- AASraw Steroid powder
Oxandrolone (Anavar) powder (CAS 53-39-4 )COA- AASraw Steroid powdersteroids raw powder source
 
Chemistry
ChemistryChemistry
Chemistryolivin6
 
IA on efficiency of immobilized enzyme amylase (fungal extract) in alginate b...
IA on efficiency of immobilized enzyme amylase (fungal extract) in alginate b...IA on efficiency of immobilized enzyme amylase (fungal extract) in alginate b...
IA on efficiency of immobilized enzyme amylase (fungal extract) in alginate b...Lawrence kok
 
Preparation of reagents for Qualitative analysis of salts MANIK
Preparation of reagents  for Qualitative analysis of salts MANIKPreparation of reagents  for Qualitative analysis of salts MANIK
Preparation of reagents for Qualitative analysis of salts MANIKImran Nur Manik
 
Synthesis of Aspirin lab chem 165
Synthesis of Aspirin lab chem 165Synthesis of Aspirin lab chem 165
Synthesis of Aspirin lab chem 165Rasan Cherala
 
Fibrecrafts colour crafts
Fibrecrafts colour craftsFibrecrafts colour crafts
Fibrecrafts colour craftsquochungdye
 
Practical Experiment 8: To synthesize and characterized barbaturic acid
Practical Experiment 8: To synthesize and characterized barbaturic acid Practical Experiment 8: To synthesize and characterized barbaturic acid
Practical Experiment 8: To synthesize and characterized barbaturic acid SONALI PAWAR
 
IA on rate of hydrolysis of aspirin at different temperature, measured using ...
IA on rate of hydrolysis of aspirin at different temperature, measured using ...IA on rate of hydrolysis of aspirin at different temperature, measured using ...
IA on rate of hydrolysis of aspirin at different temperature, measured using ...Lawrence kok
 
IA on efficiency of immobilized enzyme amylase (yeast extract) in alginate be...
IA on efficiency of immobilized enzyme amylase (yeast extract) in alginate be...IA on efficiency of immobilized enzyme amylase (yeast extract) in alginate be...
IA on efficiency of immobilized enzyme amylase (yeast extract) in alginate be...Lawrence kok
 
Proximate analysis of Macro Nutrients
Proximate analysis of Macro NutrientsProximate analysis of Macro Nutrients
Proximate analysis of Macro NutrientsDivya Naidu
 

Tendances (20)

B. Pharm. (Honours) Part-III Practical, Medicinal Chemistry,Manik
B. Pharm. (Honours) Part-III Practical, Medicinal Chemistry,ManikB. Pharm. (Honours) Part-III Practical, Medicinal Chemistry,Manik
B. Pharm. (Honours) Part-III Practical, Medicinal Chemistry,Manik
 
Medicinal chemistry i practicals
Medicinal chemistry  i  practicalsMedicinal chemistry  i  practicals
Medicinal chemistry i practicals
 
IMViC Biochemical Tests Principle|Indole|Methyl Red|Voges Proskauer|Citrate Test
IMViC Biochemical Tests Principle|Indole|Methyl Red|Voges Proskauer|Citrate TestIMViC Biochemical Tests Principle|Indole|Methyl Red|Voges Proskauer|Citrate Test
IMViC Biochemical Tests Principle|Indole|Methyl Red|Voges Proskauer|Citrate Test
 
Proximat analysis laboratory + proximat analysis
Proximat analysis laboratory + proximat analysisProximat analysis laboratory + proximat analysis
Proximat analysis laboratory + proximat analysis
 
Medicinal chemistry (Practical) MANIK
Medicinal chemistry (Practical) MANIKMedicinal chemistry (Practical) MANIK
Medicinal chemistry (Practical) MANIK
 
Synthesis of 7 hydroxy-4-methyl coumarin
Synthesis of 7 hydroxy-4-methyl coumarinSynthesis of 7 hydroxy-4-methyl coumarin
Synthesis of 7 hydroxy-4-methyl coumarin
 
Effect of the amount of worms on Organic matter degradation in cattle manure ...
Effect of the amount of worms on Organic matter degradation in cattle manure ...Effect of the amount of worms on Organic matter degradation in cattle manure ...
Effect of the amount of worms on Organic matter degradation in cattle manure ...
 
Preparation of reagents for Qualitative analysis of salts MANIK
Preparation of reagents  for Qualitative analysis of salts MANIKPreparation of reagents  for Qualitative analysis of salts MANIK
Preparation of reagents for Qualitative analysis of salts MANIK
 
exp 5 - aspirinf11.pdf
exp 5 - aspirinf11.pdfexp 5 - aspirinf11.pdf
exp 5 - aspirinf11.pdf
 
Oxandrolone (Anavar) powder (CAS 53-39-4 )COA- AASraw Steroid powder
Oxandrolone (Anavar) powder (CAS 53-39-4 )COA- AASraw Steroid powderOxandrolone (Anavar) powder (CAS 53-39-4 )COA- AASraw Steroid powder
Oxandrolone (Anavar) powder (CAS 53-39-4 )COA- AASraw Steroid powder
 
Chemistry
ChemistryChemistry
Chemistry
 
IA on efficiency of immobilized enzyme amylase (fungal extract) in alginate b...
IA on efficiency of immobilized enzyme amylase (fungal extract) in alginate b...IA on efficiency of immobilized enzyme amylase (fungal extract) in alginate b...
IA on efficiency of immobilized enzyme amylase (fungal extract) in alginate b...
 
Preparation of reagents for Qualitative analysis of salts MANIK
Preparation of reagents  for Qualitative analysis of salts MANIKPreparation of reagents  for Qualitative analysis of salts MANIK
Preparation of reagents for Qualitative analysis of salts MANIK
 
Synthesis of Aspirin lab chem 165
Synthesis of Aspirin lab chem 165Synthesis of Aspirin lab chem 165
Synthesis of Aspirin lab chem 165
 
Fibrecrafts colour crafts
Fibrecrafts colour craftsFibrecrafts colour crafts
Fibrecrafts colour crafts
 
Practical Experiment 8: To synthesize and characterized barbaturic acid
Practical Experiment 8: To synthesize and characterized barbaturic acid Practical Experiment 8: To synthesize and characterized barbaturic acid
Practical Experiment 8: To synthesize and characterized barbaturic acid
 
IA on rate of hydrolysis of aspirin at different temperature, measured using ...
IA on rate of hydrolysis of aspirin at different temperature, measured using ...IA on rate of hydrolysis of aspirin at different temperature, measured using ...
IA on rate of hydrolysis of aspirin at different temperature, measured using ...
 
Quality testing of spices
Quality testing of spicesQuality testing of spices
Quality testing of spices
 
IA on efficiency of immobilized enzyme amylase (yeast extract) in alginate be...
IA on efficiency of immobilized enzyme amylase (yeast extract) in alginate be...IA on efficiency of immobilized enzyme amylase (yeast extract) in alginate be...
IA on efficiency of immobilized enzyme amylase (yeast extract) in alginate be...
 
Proximate analysis of Macro Nutrients
Proximate analysis of Macro NutrientsProximate analysis of Macro Nutrients
Proximate analysis of Macro Nutrients
 

En vedette

An Analysis of Amoxicillin Through GCMS and Later FTIR
An Analysis of Amoxicillin Through GCMS and Later FTIRAn Analysis of Amoxicillin Through GCMS and Later FTIR
An Analysis of Amoxicillin Through GCMS and Later FTIRKirk Teegardin
 
XVII Jornadas de Estudios de Lingüística: lenguaje y deporte
XVII Jornadas de Estudios de Lingüística: lenguaje y deporteXVII Jornadas de Estudios de Lingüística: lenguaje y deporte
XVII Jornadas de Estudios de Lingüística: lenguaje y deporteMaría del Carmen Méndez Santos
 
Smokeless Tobacco and Oral Cancer
Smokeless Tobacco and Oral CancerSmokeless Tobacco and Oral Cancer
Smokeless Tobacco and Oral CancerSteven Kizior
 
Information wants to be free
Information wants to be freeInformation wants to be free
Information wants to be freeEric Tachibana
 
8ink 기획서V1 0 김수현,유지은
8ink 기획서V1 0 김수현,유지은8ink 기획서V1 0 김수현,유지은
8ink 기획서V1 0 김수현,유지은jin_yoo
 
医用画像情報イントロダクション Ver.1 0_20160726
医用画像情報イントロダクション Ver.1 0_20160726医用画像情報イントロダクション Ver.1 0_20160726
医用画像情報イントロダクション Ver.1 0_20160726Tatsuaki Kobayashi
 
PEDIDO DE PROVIDÊNCIA 814
PEDIDO DE PROVIDÊNCIA 814PEDIDO DE PROVIDÊNCIA 814
PEDIDO DE PROVIDÊNCIA 814vereadoreduardo
 
Day 1 Reflection at #SXSW 2013 -- #SXSWOgilvy
Day 1 Reflection at #SXSW 2013 -- #SXSWOgilvy Day 1 Reflection at #SXSW 2013 -- #SXSWOgilvy
Day 1 Reflection at #SXSW 2013 -- #SXSWOgilvy Ogilvy Consulting
 
Para que una sociedad pueda vivir feliz
Para que una sociedad pueda vivir felizPara que una sociedad pueda vivir feliz
Para que una sociedad pueda vivir felizMariaIssabell
 
効果的なXPの導入を目的とした プラクティス間の相互作用の分析
効果的なXPの導入を目的とした プラクティス間の相互作用の分析効果的なXPの導入を目的とした プラクティス間の相互作用の分析
効果的なXPの導入を目的とした プラクティス間の相互作用の分析Makoto SAKAI
 
The sps code of conduct 2011
The sps code of conduct 2011The sps code of conduct 2011
The sps code of conduct 2011bambangsaja
 
Boston p camp introducing pmf v3.3 - Steve Wells at ProductCamp Boston, Ap...
Boston p camp   introducing pmf  v3.3 - Steve Wells at ProductCamp Boston, Ap...Boston p camp   introducing pmf  v3.3 - Steve Wells at ProductCamp Boston, Ap...
Boston p camp introducing pmf v3.3 - Steve Wells at ProductCamp Boston, Ap...ProductCamp Boston
 
8 kl vostochno-evropeyskaya_ravnina
8 kl vostochno-evropeyskaya_ravnina8 kl vostochno-evropeyskaya_ravnina
8 kl vostochno-evropeyskaya_ravninaones123
 
Recommendation Letter - Xiuting
Recommendation Letter - XiutingRecommendation Letter - Xiuting
Recommendation Letter - XiutingXiuting Hao
 
Presentación final
Presentación finalPresentación final
Presentación finaldocentecis
 
8 Truths About Exercising presented by Terry Febrey
8 Truths About Exercising presented by Terry Febrey8 Truths About Exercising presented by Terry Febrey
8 Truths About Exercising presented by Terry FebreyTerry Febrey
 

En vedette (20)

An Analysis of Amoxicillin Through GCMS and Later FTIR
An Analysis of Amoxicillin Through GCMS and Later FTIRAn Analysis of Amoxicillin Through GCMS and Later FTIR
An Analysis of Amoxicillin Through GCMS and Later FTIR
 
Ms word1
Ms word1Ms word1
Ms word1
 
XVII Jornadas de Estudios de Lingüística: lenguaje y deporte
XVII Jornadas de Estudios de Lingüística: lenguaje y deporteXVII Jornadas de Estudios de Lingüística: lenguaje y deporte
XVII Jornadas de Estudios de Lingüística: lenguaje y deporte
 
Smokeless Tobacco and Oral Cancer
Smokeless Tobacco and Oral CancerSmokeless Tobacco and Oral Cancer
Smokeless Tobacco and Oral Cancer
 
3º A 2015
3º A 20153º A 2015
3º A 2015
 
Information wants to be free
Information wants to be freeInformation wants to be free
Information wants to be free
 
8ink 기획서V1 0 김수현,유지은
8ink 기획서V1 0 김수현,유지은8ink 기획서V1 0 김수현,유지은
8ink 기획서V1 0 김수현,유지은
 
医用画像情報イントロダクション Ver.1 0_20160726
医用画像情報イントロダクション Ver.1 0_20160726医用画像情報イントロダクション Ver.1 0_20160726
医用画像情報イントロダクション Ver.1 0_20160726
 
PEDIDO DE PROVIDÊNCIA 814
PEDIDO DE PROVIDÊNCIA 814PEDIDO DE PROVIDÊNCIA 814
PEDIDO DE PROVIDÊNCIA 814
 
Day 1 Reflection at #SXSW 2013 -- #SXSWOgilvy
Day 1 Reflection at #SXSW 2013 -- #SXSWOgilvy Day 1 Reflection at #SXSW 2013 -- #SXSWOgilvy
Day 1 Reflection at #SXSW 2013 -- #SXSWOgilvy
 
Para que una sociedad pueda vivir feliz
Para que una sociedad pueda vivir felizPara que una sociedad pueda vivir feliz
Para que una sociedad pueda vivir feliz
 
効果的なXPの導入を目的とした プラクティス間の相互作用の分析
効果的なXPの導入を目的とした プラクティス間の相互作用の分析効果的なXPの導入を目的とした プラクティス間の相互作用の分析
効果的なXPの導入を目的とした プラクティス間の相互作用の分析
 
The sps code of conduct 2011
The sps code of conduct 2011The sps code of conduct 2011
The sps code of conduct 2011
 
Boston p camp introducing pmf v3.3 - Steve Wells at ProductCamp Boston, Ap...
Boston p camp   introducing pmf  v3.3 - Steve Wells at ProductCamp Boston, Ap...Boston p camp   introducing pmf  v3.3 - Steve Wells at ProductCamp Boston, Ap...
Boston p camp introducing pmf v3.3 - Steve Wells at ProductCamp Boston, Ap...
 
8 kl vostochno-evropeyskaya_ravnina
8 kl vostochno-evropeyskaya_ravnina8 kl vostochno-evropeyskaya_ravnina
8 kl vostochno-evropeyskaya_ravnina
 
Recommendation Letter - Xiuting
Recommendation Letter - XiutingRecommendation Letter - Xiuting
Recommendation Letter - Xiuting
 
Presentación final
Presentación finalPresentación final
Presentación final
 
日本
日本日本
日本
 
8 Truths About Exercising presented by Terry Febrey
8 Truths About Exercising presented by Terry Febrey8 Truths About Exercising presented by Terry Febrey
8 Truths About Exercising presented by Terry Febrey
 
94 1006-1-pb
94 1006-1-pb94 1006-1-pb
94 1006-1-pb
 

Similaire à An Analysis of Amoxicillin Through GC/MS and Later FTIR Presentation

Shrinivas colloquium 18_06_10
Shrinivas colloquium 18_06_10Shrinivas colloquium 18_06_10
Shrinivas colloquium 18_06_10Shrinivas Shete
 
Pesticide Presentation
Pesticide PresentationPesticide Presentation
Pesticide PresentationKaren Sanders
 
Analysis of organic acetates in e-vapor products by GC-MS/MS
Analysis of organic acetates in e-vapor products by GC-MS/MSAnalysis of organic acetates in e-vapor products by GC-MS/MS
Analysis of organic acetates in e-vapor products by GC-MS/MSRana Tayyarah
 
My Biofuels Research
My Biofuels ResearchMy Biofuels Research
My Biofuels ResearchJamie Nervil
 
PRESENTATION SIRIM
PRESENTATION SIRIMPRESENTATION SIRIM
PRESENTATION SIRIMAmeen Rahman
 
Proximate and non-proximate parameters analysis of food.pptx
Proximate and non-proximate  parameters analysis of food.pptxProximate and non-proximate  parameters analysis of food.pptx
Proximate and non-proximate parameters analysis of food.pptxmasresha10
 
Special tests for antinutritional and toxic factors in poultry feeds
Special tests for antinutritional and toxic factors in poultry feedsSpecial tests for antinutritional and toxic factors in poultry feeds
Special tests for antinutritional and toxic factors in poultry feedsDr. Waqas Nawaz
 
Chemical Tests - PDW final 2.11.2014
Chemical Tests - PDW final 2.11.2014Chemical Tests - PDW final 2.11.2014
Chemical Tests - PDW final 2.11.2014SATISH KUMAR
 
An 72649-ic-limit-choline-test-an72649-en
An 72649-ic-limit-choline-test-an72649-enAn 72649-ic-limit-choline-test-an72649-en
An 72649-ic-limit-choline-test-an72649-ensmalnif
 
Life science products of GL Sciences
Life science products of GL SciencesLife science products of GL Sciences
Life science products of GL SciencesGeert Alkema
 
Dna fingerprinting matreilas & methods of chilli
Dna fingerprinting matreilas & methods of chilliDna fingerprinting matreilas & methods of chilli
Dna fingerprinting matreilas & methods of chillisachin subba
 

Similaire à An Analysis of Amoxicillin Through GC/MS and Later FTIR Presentation (20)

Shrinivas colloquium 18_06_10
Shrinivas colloquium 18_06_10Shrinivas colloquium 18_06_10
Shrinivas colloquium 18_06_10
 
DrugsofAbuseNarc2-2009
DrugsofAbuseNarc2-2009DrugsofAbuseNarc2-2009
DrugsofAbuseNarc2-2009
 
Pesticide Presentation
Pesticide PresentationPesticide Presentation
Pesticide Presentation
 
Analysis of organic acetates in e-vapor products by GC-MS/MS
Analysis of organic acetates in e-vapor products by GC-MS/MSAnalysis of organic acetates in e-vapor products by GC-MS/MS
Analysis of organic acetates in e-vapor products by GC-MS/MS
 
My Biofuels Research
My Biofuels ResearchMy Biofuels Research
My Biofuels Research
 
Metico Syrup Room Report
Metico Syrup Room ReportMetico Syrup Room Report
Metico Syrup Room Report
 
Pesticide residue analysis
Pesticide residue analysisPesticide residue analysis
Pesticide residue analysis
 
PRESENTATION SIRIM
PRESENTATION SIRIMPRESENTATION SIRIM
PRESENTATION SIRIM
 
Thesis presentation
Thesis presentationThesis presentation
Thesis presentation
 
Proximate and non-proximate parameters analysis of food.pptx
Proximate and non-proximate  parameters analysis of food.pptxProximate and non-proximate  parameters analysis of food.pptx
Proximate and non-proximate parameters analysis of food.pptx
 
Special tests for antinutritional and toxic factors in poultry feeds
Special tests for antinutritional and toxic factors in poultry feedsSpecial tests for antinutritional and toxic factors in poultry feeds
Special tests for antinutritional and toxic factors in poultry feeds
 
Chemical Tests - PDW final 2.11.2014
Chemical Tests - PDW final 2.11.2014Chemical Tests - PDW final 2.11.2014
Chemical Tests - PDW final 2.11.2014
 
An 72649-ic-limit-choline-test-an72649-en
An 72649-ic-limit-choline-test-an72649-enAn 72649-ic-limit-choline-test-an72649-en
An 72649-ic-limit-choline-test-an72649-en
 
Life science products of GL Sciences
Life science products of GL SciencesLife science products of GL Sciences
Life science products of GL Sciences
 
Dna fingerprinting matreilas & methods of chilli
Dna fingerprinting matreilas & methods of chilliDna fingerprinting matreilas & methods of chilli
Dna fingerprinting matreilas & methods of chilli
 
Production of mea triazine m1
Production of  mea triazine m1Production of  mea triazine m1
Production of mea triazine m1
 
Lab discussion
Lab discussionLab discussion
Lab discussion
 
posterIPS
posterIPSposterIPS
posterIPS
 
Poster_Jaume_120x90.01cm
Poster_Jaume_120x90.01cmPoster_Jaume_120x90.01cm
Poster_Jaume_120x90.01cm
 
Chinese tcs sample report
Chinese tcs sample    reportChinese tcs sample    report
Chinese tcs sample report
 

Dernier

THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONTHEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONHumphrey A Beña
 
ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4MiaBumagat1
 
Global Lehigh Strategic Initiatives (without descriptions)
Global Lehigh Strategic Initiatives (without descriptions)Global Lehigh Strategic Initiatives (without descriptions)
Global Lehigh Strategic Initiatives (without descriptions)cama23
 
How to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPHow to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPCeline George
 
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...Postal Advocate Inc.
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17Celine George
 
Music 9 - 4th quarter - Vocal Music of the Romantic Period.pptx
Music 9 - 4th quarter - Vocal Music of the Romantic Period.pptxMusic 9 - 4th quarter - Vocal Music of the Romantic Period.pptx
Music 9 - 4th quarter - Vocal Music of the Romantic Period.pptxleah joy valeriano
 
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITYISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITYKayeClaireEstoconing
 
ROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxVanesaIglesias10
 
Integumentary System SMP B. Pharm Sem I.ppt
Integumentary System SMP B. Pharm Sem I.pptIntegumentary System SMP B. Pharm Sem I.ppt
Integumentary System SMP B. Pharm Sem I.pptshraddhaparab530
 
Activity 2-unit 2-update 2024. English translation
Activity 2-unit 2-update 2024. English translationActivity 2-unit 2-update 2024. English translation
Activity 2-unit 2-update 2024. English translationRosabel UA
 
ICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfVanessa Camilleri
 
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfJemuel Francisco
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxHumphrey A Beña
 
4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptxmary850239
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for BeginnersSabitha Banu
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designMIPLM
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptxmary850239
 

Dernier (20)

YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptxYOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
 
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONTHEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
 
ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4
 
Global Lehigh Strategic Initiatives (without descriptions)
Global Lehigh Strategic Initiatives (without descriptions)Global Lehigh Strategic Initiatives (without descriptions)
Global Lehigh Strategic Initiatives (without descriptions)
 
How to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPHow to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERP
 
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17
 
Music 9 - 4th quarter - Vocal Music of the Romantic Period.pptx
Music 9 - 4th quarter - Vocal Music of the Romantic Period.pptxMusic 9 - 4th quarter - Vocal Music of the Romantic Period.pptx
Music 9 - 4th quarter - Vocal Music of the Romantic Period.pptx
 
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITYISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
 
ROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptx
 
Integumentary System SMP B. Pharm Sem I.ppt
Integumentary System SMP B. Pharm Sem I.pptIntegumentary System SMP B. Pharm Sem I.ppt
Integumentary System SMP B. Pharm Sem I.ppt
 
Activity 2-unit 2-update 2024. English translation
Activity 2-unit 2-update 2024. English translationActivity 2-unit 2-update 2024. English translation
Activity 2-unit 2-update 2024. English translation
 
ICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdf
 
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
 
4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for Beginners
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-design
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx
 
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptxFINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
 

An Analysis of Amoxicillin Through GC/MS and Later FTIR Presentation

  • 1.
  • 2.  Establish the importance of the experiment ◦ Handouts ◦ Surveymonkey.com  62 participants
  • 3. 63% 37% Question 1: Do you purchases pharmaceuticals in Mexico? Yes No 14% 39% 18% 29% Question 2: Why do you not purchase the products in Mexico? Do Not Trust Them Unsafe to Travel There Too Far Away Other
  • 5. Yes 62% No 30% They Are Better 8% Question 11: Do you believe that they are of the same quality? Cheaper 69% No Prescription Is Needed 10% I Live There 5% Other 16% Question 9: What is the primary reason you purchase Pharmaceuticals in Mexico?
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 12.  A method to chemically modify a compound ◦ Increase volatility ◦ Decrease volatility  Focuses on O, S, N, and P functional groups with an active Hydrogen available
  • 13.  Silylation produces silyl derivatives to increase volatility. ◦ Replaces active H with TMS. ◦ Solvent = Pyridine  Acylation target carbohydrates and amino acids  Alkylation converts organic acids into esters by transferring an alkyl group
  • 14. C16H19N3O5S = 365.4 grams/mol
  • 15.  MTBSTFA = C9H18F3NOSi  (n-methyl-n-t-butyldimethylsilytrifluoroacetamide) ◦ 10,000 times more stable ◦ Suitable for GC/MS analysis C6H15Si 115.27 g/mol C9H18F3NOSi 241.33 g/mol +
  • 16.
  • 17.  0.0154 grams Amoxicillin  100 µL 0.85 M Acetonitrile  20 µL MTBSTFA  Sat Overnight  150 µL Hexane  *Centrifuged 15 Minutes  1 mL of Hexane (solvent)
  • 18.
  • 19. GC Parameters:  Inlet – 240 ºC  Oven temp. start at 60 ºC,  Ramp up to 300 ºC at 40 ºC/min  Flow rate of He = 1mL/min.  Splitless MS Parameters:  Ion mode - 70 ev  Solvent Delay 3 min.  Scan – 50-500 amu
  • 20.
  • 21. S1  0.1002 g of Amoxicillin  100 µL of Acetonitrile  1 mL of Pyridine (Solvent)  20 µL of MTBSTFA S2  0.1012 g of Amoxicillin  100 µL of Acetonitrile  1 mL of Methanol (Solvent)  20 µL of MTBSTFA S1 & S2  *Centrifuged 20 min.  Water bath 100 ºC 20 min.
  • 22. GC Parameters:  Inlet – 250 ºC  Oven temp. start at 40 ºC,  Ramp up to 340 ºC at 20 ºC/min  Flow rate of He = 1mL/min.  Splitless MS Parameters:  Ion mode - 70 ev  Solvent Delay 3 min.  Scan – 50-500 amu
  • 23. 60 ºC  0.0983 g of Amoxicillin  100 µL of Acetonitrile  1 mL of Pyridine (Solvent)  20 µL of MTBSTFA  *Centrifuged 20 minutes  Water Bath 60 ºC 1 hour 40 ºC  0.1012 g of Amoxicillin  100 µL of Acetonitrile  1 mL of Methanol (Solvent)  20 µL of MTBSTFA  *Centrifuged 20 minutes  Water Bath 40 ºC 1 hour
  • 24. GC Parameters:  Inlet – 250 ºC  Oven temp. start at 40 ºC,  Ramp up to 340 ºC at 20 ºC/min  Flow rate of He = 1mL/min.  Splitless MS Parameters:  Ion mode - 70 ev  Solvent Delay 3 min.  Scan – 50-600 amu
  • 25.
  • 26.
  • 27.
  • 28. Handedness  Chiral Molecule is a molecule that is the same but arranged in a non- superimposable way, typically due to Carbon  C8H12N2O3S  MW = 216.0568 H
  • 29. GC Parameters:  Inlet – 250 ºC  Oven temp. start at 40 ºC,  Ramp up to 340 ºC at 20 ºC/min  Flow rate of He = 1mL/min.  Splitless MS Parameters:  Ion mode - 70 ev  Solvent Delay 3 min.  Scan – 50-600 amu
  • 30. GC Parameters:  Inlet – 250 ºC  Oven temp. start at 40 ºC,  Ramp up to 340 ºC at 20 ºC/min  Flow rate of He = 1mL/min.  Splitless MS Parameters:  Ion mode - 70 ev  Solvent Delay 3 min.  Scan – 50-600 amu
  • 31. Standard 1  0.1016 g of Amoxicillin  100 µL of Acetonitrile  1 mL of Pyridine (Solvent)  20 µL of MTBSTFA Standard 2  0.0751 g of Amoxicillin  100 µL of Acetonitrile  1 mL of Pyridine (Solvent)  20 µL of MTBSTFA Standard 3  0.0492 g of Amoxicillin  100 µL of Acetonitrile  1 mL of Pyridine (Solvent)  20 µL of MTBSTFA Standard 4  0.0246 g of Amoxicillin  100 µL of Acetonitrile  1 mL of Pyridine (Solvent)  20 µL of MTBSTFA Standards 1-4  *Centrifuged 20 min.  Water bath 100 ºC 20 min. GC Parameters:  Inlet – 300 ºC  Oven temp. start at 40 ºC,  Ramp up to 340 ºC at 20 ºC/min  Flow rate of He = 1mL/min.  Splitless MS Parameters:  Ion mode - 70 ev  Solvent Delay 3 min.  SCAN - 50-600 amu
  • 32. GC Parameters:  Inlet – 300 ºC  Oven temp. start at 40 ºC,  Ramp up to 340 ºC at 20 ºC/min  Flow rate of He = 1mL/min.  Splitless MS Parameters:  Ion mode - 70 ev  Solvent Delay 3 min.  SCAN – 50-600 amu
  • 33. y = 48.303x + 3E+06 R² = 0.468 0 2000000 4000000 6000000 8000000 10000000 0 20000 40000 60000 80000 100000 Area Concentration (PPM) Graph 1: Concentration (PPM) Versus Area y = 48.303x + 3E+06 R² = 0.5253 0 2000000 4000000 6000000 8000000 10000000 0 20000 40000 60000 80000 100000 Area Concentration (PPM) Graph 2: Concentration Averages (PPM) Versus Area Averages Name Concentration (PPM) Area Average Areas Standard 4 21964 3124602 Standard 4 21964 3059293 Standard 4 21964 3087453 Standard 3 43929 7201948 Standard 3 43929 6591084 Standard 3 43929 6425105 Standard 2 67054 8825625 Standard 2 67054 7083085 Standard 2 67054 6681811 Standard 1 90714 6788287 Standard 1 90714 5668981 Standard 1 90714 7278867 3090449.333 6739379 7530173.667 6578711.667 Table 1: Concentration Versus Areas
  • 34. GC Parameters:  Inlet – 250 ºC  Oven temp. start at 40 ºC,  Ramp up to 340 ºC at 20 ºC/min  Flow rate of He = 1mL/min.  Splitless MS Parameters:  Ion mode - 70 ev  Solvent Delay 3 min.  SIM – 114, 142.5, 160 amu
  • 35.  Syringe filtered standards into new vials  Ran sequence in SIM Mode - 160 m/z  Results were inconclusive  Build up suspected
  • 36.  Stock Solution 1026 PPM Amoxicillin  Made 1000 PPB solution of Amoxicillin Standard 1  2 mL of 1000 PPB Solution  0.5 mL of 5 N KOH Standard 2  1 mL of 1000 PPB Solution  1 mL of DI Water  0.5 mL of 5 N KOH Standard 3  0.5 mL of 1000 PPB Solution  1.5 mL of DI Water  0.5 mL of 5 N KOH Standards 1-3  Water bath 50 ºC 20 min.  Cooled for 60 Minutes  + 1 mL of Acetic Acid  + 5 mL of (7:1 ratio) Hexane: Ethyl Acetate solution  Centrifuged for 15 minutes  Top organic layer extracted to new test tubes  Evaporated to dryness (several days)  + 20 μL of MTBSTFA  + 100 μL of Acetonitrile  Heated in heating block at 110 °C for 15 minutes  + 0.5 methanol solvent  Each standard tested several times  No signs of Amoxicillin or 6- Aminopenicillanic Acid
  • 37.  Batch 4 standard dilutions  100 μL of each respective standard into new vial  + 900 μL of Methanol solvent  No signs of Amoxicillin or 6-Aminopenllinc Acid
  • 38. Test Samples 1 & 2  Water bath 60 ºC 15 min.  Cooled for 60 minutes  + 1 mL of Acetic Acid  + 5 mL of (7:1 ratio) Hexane: Ethyl Acetate solution  Centrifuged for 15 minutes  Top organic layer extracted to new test tubes  Evaporated to dryness (several days)  + 20 μL of MTBSTFA  + 100 μL of Acetonitrile  Heated in heating block at 110 °C for 15 minutes  + 0.5 methanol solvent  New Stock Solution of 10,000 PPM Amoxicillin Test Sample 1  2 mL of 1000 PPM Stock Solution  0.5 mL of 5 N KOH Test Sample 2  2 mL of 10,000 PPM Stock Solution  0.5 mL of 5 N KOH  Each test sample tested several times  No signs of Amoxicillin or 6- Aminopenllinc Acid
  • 39.  Temperature affects the 8.10 peak of 6- Aminopenicillanic Acid  Amoxicillin as a whole cannot be seen in GC/MS
  • 40.
  • 41. Standard 1  0.9916 grams of KBR  0.0017 grams of Amoxicillin  0.1026 grams of Starch Standard 2  0.9970 grams of KBR  0.0034 grams of Amoxicillin  0.1003 grams of Starch Standard 3  1.006 grams of KBR  0.0073 grams of Amoxicillin  0.1000 grams of Starch Standard 1-3  Each standard tested 3 times  Starch Wavelength Height Ratios = 2150  Amoxicillin's Wavelength Height Ratios = 1775, 1687, 1686, 1685.5, 1519
  • 43. Starch Abs. Ratio 1 Ratio 2 Ratio 3 Ratio 4 Ratio 5 Amox 1775 1687 1686 1685.5 1519 Height 2150 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150 Percentage 1 1.0940 1.5688 1.5560 1.5855 1.4680 0.8225 1.3301 1.9074 1.8918 1.9277 1.7848 1.630% 2 1.1990 1.5670 1.5550 1.5827 1.4540 0.8651 1.3860 1.8114 1.7975 1.8295 1.6807 1.630% 3 1.1150 1.5706 1.5570 1.5881 1.4740 0.8749 1.2744 1.7952 1.7796 1.8152 1.6848 1.630% Averages 1.1360 1.5688 1.5560 1.5854 1.4653 0.8542 1.3302 1.8380 1.8230 1.8574 1.7168 1.630% Starch Abs. Ratio 1 Ratio 2 Ratio 3 Ratio 4 Ratio 5 Amox 1775 1687 1686 1685.5 1519 Height 2150 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150 Percentage 1 1.2554 1.5946 1.6020 1.6060 1.4403 0.7923 1.5845 2.0126 2.0220 2.0270 1.8179 3.2787% 2 1.2709 1.5905 1.5599 1.6060 1.4439 0.8025 1.5837 1.9819 1.9438 2.0012 1.7993 3.2787% 3 1.2735 1.5934 1.6031 1.6084 1.4416 0.8105 1.5713 1.9659 1.9779 1.9845 1.7787 3.2787% Averages 1.2666 1.5928 1.5883 1.6068 1.4419 0.8018 1.5798 1.9868 1.9812 2.0042 1.7986 3.2787% Starch Abs. Ratio 1 Ratio 2 Ratio 3 Ratio 4 Ratio 5 Amox 1775 1687 1686 1685.5 1519 Height 2150 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150 Percentage 1 1.7942 2.2060 2.2900 2.2400 1.8740 1.0290 1.7436 2.1438 2.2255 2.1769 1.8212 6.8034% 2 1.7975 2.2030 2.2180 2.2260 1.8710 1.0395 1.7292 2.1193 2.1337 2.1414 1.7999 6.8034% 3 1.7856 2.2005 2.2165 2.0140 1.8935 0.9207 1.9394 2.3900 2.4074 2.1875 2.0566 6.8034% Averages 1.7924 2.2032 2.2415 2.1600 1.8795 0.9964 1.8041 2.2177 2.2555 2.1678 1.8926 6.8034% Table 1: Standard 1 Data Table 2: Standard 2 Data Table 3: Standard 3 Data Run Amoxicillin At Absorbance Height Run Amoxicillin At Absorbance Height Run Amoxicillin At Absorbance Height 1.0940/0.8225 = 1.3301 (0.0017g Amox/ (0.0017g Amox + 0.1026 g Starch)) = 1.630% Y Axis X Axis
  • 44.
  • 45. Starch Abs. Ratio 1 Ratio 2 Ratio 3 Ratio 4 Ratio 5 1775 1687 1686 1685.5 1519 Height 2150 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150 1 - - - - - 0.5355 - - - - - 2 - 3.9652 3.8270 3.7990 2.6780 0.5347 - 7.4157 7.1573 7.1049 5.0084 3 - 3.5608 3.5601 3.5599 2.6500 0.5342 - 6.6657 6.6644 6.6640 4.9607 Averages - 3.7630 3.6936 3.6795 2.6640 0.5348 - 7.0407 6.9108 6.8845 4.9846 Table 4: Average Ratios for Sample 1 Amoxicillin At Absorbance Height Run Ratio 1 Ratio 2 Ratio 3 Ratio 4 Ratio 5 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150 1 - - - - - - - - - - 2 - 7.4157 7.1573 7.1049 5.0084 - 78.7612% 66.0248% 91.9826% 101.5664% 3 - 6.6657 6.6644 6.6640 4.9607 - 68.3662% 60.0643% 84.3602% 100.1124% Averages - 7.0407 6.9108 6.8845 4.9846 - 73.5637% 63.0445% 88.1714% 100.8394% Run Percentage Based Off of Calibration Curve With Respective Ratio Table 5: Sample 1 Determined Average Percentage Based of Multiple Calibration Curves With Respective Height Ratios Weight of Pill (g) 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150 1 - - - - - - - - - - 2 - 78.7612% 66.0248% 91.9826% 101.5664% - 498.0068 417.4748 581.6061 642.2041 3 - 68.3662% 60.0643% 84.3602% 100.1124% - 432.2795 379.7866 533.4094 633.0106 Averages - 73.5637% 63.0445% 88.1714% 100.8394% - 465.1431 398.6307 557.5078 637.6074 - 46.4762 26.6496 34.0802 6.5008 - 465.14 ± 46.48 398.63 ± 26.65 557.51 ± 34.08 637.61 ± 6.50 (+) - 672.6441 517.6123 709.6647 666.6314 (-) - 257.6421 279.6491 405.3509 608.5833 Standard Deviation of Average Content of Amoxicillin (mg) Concentration of Amoxicillin (mg) and Standard Deviation 95% Confidence Interval of Amoxicillin (mg) ±Range Run Percent Based Off of Calibration Curve With Respective Ratio 0.6323 Concentration (mg) Based Off of Wegiht of Pill and % Table 6: Sample 1 Determined Concentration (mg) of Amoxicillin Determined from the Weight Pill (g) & Percentage ((7.4157 – 1.7325)/7.2158)) = 78.7612%0.6323 g X 78.7612% = 498.0068 3.9650/0.5347 = 7.4157
  • 46. Starch Abs. Ratio 1 Ratio 2 Ratio 3 Ratio 4 Ratio 5 1775 1687 1686 1685.5 1519 Height 2150 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150 1 2.5618 2.4935 2.5085 2.5160 1.9151 0.4569 5.6069 5.4574 5.4903 5.5067 4.1915 2 2.6050 2.4635 2.4862 2.4975 1.9185 0.4585 5.6816 5.3730 5.4225 5.4471 4.1843 3 2.5980 2.4507 2.4546 2.4560 1.9208 0.4579 5.6737 5.3520 5.3606 5.3636 4.1948 Averages 2.5883 2.4692 2.4831 2.4898 1.9181 0.4578 5.6541 5.3941 5.4244 5.4391 4.1902 Table 7: Average Ratios for Sample 2 Run Amoxicillin At Absorbance Height Ratio 1 Ratio 2 Ratio 3 Ratio 4 Ratio 5 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150 1 5.6069 5.4574 5.4903 5.5067 4.1915 50.1877% 51.6219% 45.8671% 64.3538% 76.6796% 2 5.6816 5.3730 5.4225 5.4471 4.1843 51.0439% 50.4512% 45.0473% 63.3241% 76.4599% 3 5.6737 5.3520 5.3606 5.3636 4.1948 50.9540% 50.1613% 44.2987% 61.8808% 76.7800% Averages 5.6541 5.3941 5.4244 5.4391 4.1902 50.7285% 50.7448% 45.0710% 63.1862% 76.6398% Table 8: Sample 2 Determined Average Percentage Based of Multiple Calibration Curves With Respective Height Ratios Run Percentage Based Off of Calibration Curve With Respective Ratio Weight of Pill (g) 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150 1 50.1877% 51.6219% 45.8671% 64.3538% 76.6796% 289.6834 297.9614 264.7447 371.4502 442.5947 2 51.0439% 50.4512% 45.0473% 63.3241% 76.4599% 294.6255 291.2041 260.0129 365.5068 441.3266 3 50.9540% 50.1613% 44.2987% 61.8808% 76.7800% 294.1063 289.5313 255.6922 357.1758 443.1740 Averages 50.7285% 50.7448% 45.0710% 63.1862% 76.6398% 292.8051 292.8989 260.1499 364.7109 442.3651 2.7159 4.4633 4.5278 7.1704 0.9448 292.81 ± 2.72 292.90 ± 4.46 260.15 ± 4.53 364.71 ± 7.17 442.37 ± 0.94 (+) 297.3837 300.4235 267.7832 376.7993 443.9579 (-) 288.2265 285.3744 252.5166 352.6226 440.7722 Concentration of Amoxicillin (mg) and Standard Deviation Concentration (mg) Based Off of Wegiht of Pill and % Table 9: Sample 2 Determined Concentration (mg) of Amoxicillin Determined from the Weight Pill (g) & Percentage Run Percent Based Off of Calibration Curve With Respective Ratio 0.5772 95% Confidence Interval of Amoxicillin (mg) ± Range Standard Deviation of Average Content of Amoxicillin (mg)
  • 47. Starch Abs. Ratio 1 Ratio 2 Ratio 3 Ratio 4 Ratio 5 1775 1687 1686 1685.5 1519 Height 2150 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150 1 4.0998 - - - 3.2080 0.7082 5.7890 - - - 4.5298 2 5.6195 3.4923 3.5105 3.5195 3.2560 0.7055 7.9653 4.9501 4.9759 4.9887 4.6152 3 3.7330 5.0030 5.1712 5.9810 3.2286 0.7037 5.3048 7.1096 7.3486 8.4994 4.5880 Averages 4.4841 4.2477 4.3409 4.7503 3.2309 0.7058 6.3530 6.0298 6.1622 6.7440 4.5777 Table 10: Average Ratios for Sample 3 Run Amoxicillin At Absorbance Height Ratio 1 Ratio 2 Ratio 3 Ratio 4 Ratio 5 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150 1 5.7890 - - - 4.5298 52.2765% - - - 86.9853% 2 7.9653 4.9501 4.9759 4.9887 4.6152 77.2359% 44.5911% 39.6474% 55.3989% 89.5862% 3 5.3048 7.1096 7.3486 8.4994 4.5880 46.7229% 74.5179% 68.3380% 116.0883% 88.7596% Averages 6.3530 6.0298 6.1622 6.7440 4.5777 58.7451% 59.5545% 53.9927% 85.7436% 88.4437% Table 11: Sample 3 Determined Average Percentage Based of Multiple Calibration Curves With Respective Height Ratios Run Percentage Based Off of Calibration Curve With Respective Ratio Weight of Pill (g) 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150 1775:2150 1687:2150 1686:2150 1685.5:2150 1519:2150 1 52.2765% - - - 86.9853% 312.7182 - - - 520.3463 2 77.2359% 44.5911% 39.6474% 55.3989% 89.5862% 462.0250 266.7441 237.1710 331.3963 535.9046 3 46.7229% 74.5179% 68.3380% 116.0883% 88.7596% 279.4965 445.7662 408.7980 694.4403 530.9601 Averages 58.7451% 59.5545% 53.9927% 85.7436% 88.4437% 351.4132 356.2551 322.9845 512.9183 529.0703 97.2221 126.5877 121.3587 256.7109 7.9494 351.41 ± 97.22 356.26 ± 126.59 322.98 ± 121.36 512.92 ± 256.71 529.07 ± 7.95 (+) 515.3164 921.4278 864.8111 1659.0482 542.4719 (-) 187.5100 -208.9175 -218.8421 80.1389 515.6687 Concentration of Amoxicillin (mg) and Standard Deviation 95% Confidence Interval of Amoxicillin (mg) ± Range 0.5982 Standard Deviation of Average Content of Amoxicillin (mg) Percent Based Off of Calibration Curve With Respective Ratio Concentration (mg) Based Off of Wegiht of Pill and % Table 12: Sample 3 Determined Concentration (mg) of Amoxicillin Determined from the Weight Pill (g) & Percentage Run
  • 48. 465.14mg ± 46.48mg 292.81mg ± 2.72mg Or 442.37mg ± 0.94mg 529.07mg ± 7.95mg
  • 49.  Somewhat possible view Amoxicillin through GC/MS  Further testing of Amoxicillin Sample 2 through

Notes de l'éditeur

  1. Gas Chromatography (GC) Inlet vaporizes the sample Carrier gas pushes sample Separation occurs Peaks are produced
  2. Gas Chromatography (GC) Inlet vaporizes the sample Carrier gas pushes sample Separation occurs Peaks are produced
  3. Mass Spectrum (MS) Detector Ionization chamber (after GC column) Beam of electrons charge molecules Fragmentation occurs Accelerates through a magnetic field Fragmented molecules are detected as mass to charge ratio (m/z)
  4. FTIR – Fourier Transform Infrared Spectroscopy FTIR is an easier form of spectroscopy which measures the light that is emitted or absorbed through a sample at a wide range of wavelengths. This data provided gives information on the functional groups that are in the sample. The functional groups can then be pieced together to determine the overall sturcutre of the sample.